Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ABBV
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER | ABBV AbbVie Inc. | Sale | 40,619 | $293.60 | $11.9M Sale | Form 4 ↗ |
| Aug 14, 2026 | Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER | ABBV AbbVie Inc. | Sale | 32,710 | $250.00 | $8.2M Sale | Form 4 ↗ |
| Mar 4, 2026 | David Ryan Purdue SVP, Controller | ABBV AbbVie Inc. | Sale | 5,230 | $233.56 | $1.2M Sale | Form 4 ↗ |
| Mar 2, 2026 | Perry C. Siatis EVP, GC AND SECRETARY | ABBV AbbVie Inc. | Sale | 2,600 | $235.26 | $611.7K Sale | Form 4 ↗ |
| Mar 2, 2026 | Perry C. Siatis EVP, GC AND SECRETARY | ABBV AbbVie Inc. | Sale | 10,291 | $234.66 | $2.4M Sale | Form 4 ↗ |
| Mar 2, 2026 | Perry C. Siatis EVP, GC AND SECRETARY | ABBV AbbVie Inc. | Sale | 5,777 | $233.51 | $1.3M Sale | Form 4 ↗ |
| Feb 25, 2026 | Perry C. Siatis EVP, GC AND SECRETARY | ABBV AbbVie Inc. | Sale | 22,381 | $230.00 | $5.1M Sale | Form 4 ↗ |
| Aug 12, 2025 | Azita Saleki-Gerhardt EVP, CHIEF OPERATIONS OFFICER | ABBV AbbVie Inc. | Sale | 42,370 | $198.42 | $8.4M Sale | Form 4 ↗ |
| Aug 5, 2025 | Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER | ABBV AbbVie Inc. | Sale | 10,061 | $198.59 | $2.0M Sale | Form 4 ↗ |
| Aug 5, 2025 | Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER | ABBV AbbVie Inc. | Sale | 3,234 | $198.27 | $641.2K Sale | Form 4 ↗ |
| Mar 31, 2025 | Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER | ABBV AbbVie Inc. | Sale | 33,132 | $210.54 | $7.0M Sale | Form 4 ↗ |
| Mar 31, 2025 | Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER | ABBV AbbVie Inc. | Sale | 25,700 | $209.49 | $5.4M Sale | Form 4 ↗ |
| Mar 14, 2025 | Scott T. Reents EVP, CHIEF FINANCIAL OFFICER | ABBV AbbVie Inc. | Sale | 17,644 | $212.34 | $3.7M Sale | Form 4 ↗ |
| Mar 3, 2025 | Timothy J. Richmond EVP, CHIEF HR OFFICER | ABBV AbbVie Inc. | Sale | 600 | $211.32 | $126.8K Sale | Form 4 ↗ |
| Mar 3, 2025 | Timothy J. Richmond EVP, CHIEF HR OFFICER | ABBV AbbVie Inc. | Sale | 14,973 | $210.66 | $3.2M Sale | Form 4 ↗ |
| Mar 3, 2025 | Timothy J. Richmond EVP, CHIEF HR OFFICER | ABBV AbbVie Inc. | Sale | 5,677 | $209.80 | $1.2M Sale | Form 4 ↗ |
| Mar 3, 2025 | Richard A. Gonzalez Director | ABBV AbbVie Inc. | Sale | 6,168 | $210.53 | $1.3M Sale | Form 4 ↗ |
| Mar 3, 2025 | Perry C. Siatis EVP, GC AND SECRETARY | ABBV AbbVie Inc. | Sale | 18,008 | $210.00 | $3.8M Sale | Form 4 ↗ |
| Feb 28, 2025 | Richard A. Gonzalez Director | ABBV AbbVie Inc. | Sale | 92,460 | $205.11 | $19.0M Sale | Form 4 ↗ |
| Feb 28, 2025 | Perry C. Siatis EVP, GC AND SECRETARY | ABBV AbbVie Inc. | Sale | 363 | $207.19 | $75.2K Sale | Form 4 ↗ |
| Feb 28, 2025 | Perry C. Siatis EVP, GC AND SECRETARY | ABBV AbbVie Inc. | Sale | 6,811 | $206.62 | $1.4M Sale | Form 4 ↗ |
| Feb 28, 2025 | Perry C. Siatis EVP, GC AND SECRETARY | ABBV AbbVie Inc. | Sale | 2,718 | $205.38 | $558.2K Sale | Form 4 ↗ |
| Feb 26, 2025 | Kevin K. Buckbee SVP, CONTROLLER | ABBV AbbVie Inc. | Sale | 16,260 | $203.41 | $3.3M Sale | Form 4 ↗ |
| Feb 26, 2025 | Kevin K. Buckbee SVP, CONTROLLER | ABBV AbbVie Inc. | Sale | 2,684 | $203.40 | $545.9K Sale | Form 4 ↗ |
| Feb 26, 2025 | Timothy J. Richmond EVP, CHIEF HR OFFICER | ABBV AbbVie Inc. | Sale | 4,829 | $203.63 | $983.3K Sale | Form 4 ↗ |
| Feb 26, 2025 | Timothy J. Richmond EVP, CHIEF HR OFFICER | ABBV AbbVie Inc. | Sale | 13,073 | $202.92 | $2.7M Sale | Form 4 ↗ |
| Feb 26, 2025 | Timothy J. Richmond EVP, CHIEF HR OFFICER | ABBV AbbVie Inc. | Sale | 4,308 | $201.97 | $870.1K Sale | Form 4 ↗ |
| Feb 26, 2025 | Timothy J. Richmond EVP, CHIEF HR OFFICER | ABBV AbbVie Inc. | Sale | 1,526 | $203.64 | $310.8K Sale | Form 4 ↗ |
| Feb 26, 2025 | Timothy J. Richmond EVP, CHIEF HR OFFICER | ABBV AbbVie Inc. | Sale | 4,781 | $202.93 | $970.2K Sale | Form 4 ↗ |
| Feb 26, 2025 | Timothy J. Richmond EVP, CHIEF HR OFFICER | ABBV AbbVie Inc. | Sale | 1,400 | $202.06 | $282.9K Sale | Form 4 ↗ |
| Feb 20, 2025 | Perry C. Siatis EVP, GC AND SECRETARY | ABBV AbbVie Inc. | Sale | 3,994 | $198.12 | $791.3K Sale | Form 4 ↗ |
| Feb 20, 2025 | Perry C. Siatis EVP, GC AND SECRETARY | ABBV AbbVie Inc. | Sale | 1,784 | $197.40 | $352.2K Sale | Form 4 ↗ |
| Dec 16, 2024 | Kevin K. Buckbee SVP, CONTROLLER | ABBV AbbVie Inc. | Sale | 1,800 | $172.24 | $310.0K Sale | Form 4 ↗ |
33 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:33 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances